World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 12 December 2020
Main ID:  NCT02238405
Date of registration: 22/07/2014
Prospective Registration: Yes
Primary sponsor: Johns Hopkins University
Public title: A Controlled Smoking Cessation Trial and Prospective Cohort Study of Tuberculosis (TB) Treatment Outcomes
Scientific title: A Randomized Controlled Smoking Cessation Trial and Prospective Cohort Study of TB Treatment Outcomes
Date of first enrolment: May 25, 2015
Target sample size: 350
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02238405
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Single Group Assignment. Primary purpose: Treatment. Masking: None (Open Label).  
Phase:  N/A
Countries of recruitment
Pakistan
Contacts
Name:     Jonathan E Golub, PhD
Address: 
Telephone:
Email:
Affiliation:  Johns Hopkins University
Key inclusion & exclusion criteria

Inclusion Criteria:

- Males, =18 years of age

- diagnosed with pulmonary TB

- self-reported current smokers, or smoker within 6 months

- anticipated to be attending the TB treatment clinic for at least 6 months

- be willing to set a quit date within 2 weeks after baseline assessment

- agree to participate

Exclusion Criteria:

- less than 18 years of age

- quit for more than 6 months

- extra-pulmonary TB

- unable/unwilling to provide written consent



Age minimum: 18 Years
Age maximum: N/A
Gender: Male
Health Condition(s) or Problem(s) studied
Tuberculosis
Smoking Cessation
Intervention(s)
Other: Intensive anti-smoking counseling
Primary Outcome(s)
Smoking cessation rate [Time Frame: 1-6 months]
Smoking cessation rate [Time Frame: 6 months post-TB treatment]
Secondary Outcome(s)
negative TB treatment outcome (death, treatment failure, relapse, required prolongation of TB therapy [Time Frame: 6 months post-TB treatment]
Secondary ID(s)
IRB00037636
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Global Fund
National Tuberculosis Control Program, Pakistan
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history